Acquisition highlights of CyGenica and a snapshot of its key metrics.

A snapshot of cap table and shareholder metrics

Founded in 2017, CyGenica operates in Health Tech offering non-viral, non-toxic delivery solutions for drugs, gene editing components, and antibiotics. The company focuses on overcoming the cellular membrane barrier that limits the effective delivery of large therapeutic molecules, particularly in gene therapy. By enhancing the delivery of therapeutics into target cells, CyGenica aims to reduce unwanted side effects and lower dosage requirements. The founder's personal experience with her father's cancer treatment drives the team to improve the safety and effectiveness of cancer drugs, striving to make a positive impact on patient outcomes globally.

Nusrat Jahan Sanghamitra

Funding highlights of CyGenica and a snapshot of its key metrics.

David Rowan

Golden Sparrow Ventures

Sami Mikati

Sharaf Yamani

SOSV

VOYAGERS Health-Tech Fund

Investment highlights of CyGenica and a snapshot of its key metrics.

CyGenica

A snapshot of highlights, scale, and metrics

A Health Tech Funded Company Based Out Of Pune

Decoding financial health metrics of CyGenica

CyGenica - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

CyGenica: Financial Breakdown

Disclaimer